Effect of Ruboxistaurin on Visual Loss in Patients with Diabetic Retinopathy
Authors:
- PKC-DRS2 GroupPGPKC-DRS2 Group
- Lloyd Paul AielloLALloyd Paul Aiello
- Matthew D DavisMDMatthew D Davis
- Aniz GirachAGAniz Girach
- Keri A KlesKKKeri A Kles
- Roy C MiltonRMRoy C Milton
- Matthew J SheetzMSMatthew J Sheetz
- Louis VignatiLVLouis Vignati
- Xin Eric ZhiXZXin Eric Zhi
- 1 December 2006
- journal article
- conference paper
- Published by Elsevier in Ophthalmology
- Vol. 113 (12) , 2221-2230
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Inhibition of PKC by Oral Administration of Ruboxistaurin Is Well Tolerated and Ameliorates Diabetes-Induced Retinal Hemodynamic Abnormalities in PatientsInvestigative Ophthalmology & Visual Science, 2006
- Epidemiology of diabetic retinopathy and macular oedema: a systematic reviewEye, 2004
- Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edemaOphthalmology, 2003
- Inhibition of protein kinase C decreases prostaglandin‐induced breakdown of the blood‐retinal barrierJournal of Cellular Physiology, 2003
- Development of Renal Disease in People at High Cardiovascular RiskJournal of the American Society of Nephrology, 2003
- The Microvasculature in Type 1 DiabetesSeminars in Vascular Medicine, 2002
- Protein Kinase C Signaling Regulates ZO-1 Translocation and Increased Paracellular Flux of T84 Colonocytes Exposed toClostridium difficile Toxin AJournal of Biological Chemistry, 2002
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β InhibitorScience, 1996
- PHOTOCOAGULATION FOR DIABETIC MACULAR EDEMA: EARLY TREATMENT DIABETIC RETINOPATHY STUDY REPORT NO. 4International Ophthalmology Clinics, 1987